We’re rated Excellent
4.7 out of 5 based on 100 reviews

Early Winter Weekend Reading Dec 3

Second death linked to potential antibody treatment for Alzheimer’s disease

Woman’s brain haemorrhage while receiving Eisai’s widely heralded lecanemab heightens concerns overs its safety

Second death linked to potential antibody treatment for Alzheimer’s disease | Science | AAAS                                                                                          

Bionaut Labs secures $43M for its tiny, drug-carrying robots

Bionaut Labs secures $43M for its tiny, drug-carrying robots (fiercebiotech.com)

MIT researchers reveal DNA "Paste" tech behind latest gene editing startup

MIT researchers reveal DNA – Endpoints News (endpts.com)

Cajal Neuroscience launches with $96M Series A, tackling Alzheimer's and Parkinson's

Cajal Neuroscience launches with $96M Series A, tackling Alzheimer’s and Parkinson’s – Endpoints News (endpts.com)

AstraZeneca reveals its cell therapy ambitions with deal for startup

AstraZeneca reveals its cell therapy ambitions with deal for startup | BioPharma Dive

Natural and targeted circuit reorganization after spinal cord injury

Natural and targeted circuit reorganization after spinal cord injury | Nature Neuroscience

After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback

Out of prison, ‘CRISPR babies’ scientist attempts comeback (statnews.com)

Jim Wilson biotech iECURE gets fresh $65M to push paediatric liver disease gene therapy into the clinic

Jim Wilson biotech iECURE gets fresh $65M to push paediatric liver disease gene therapy into the clinic – Endpoints News (endpts.com)

Biomarker of Early-Stage Alzheimer’s Disease Discovered in Urine

Biomarker of Early-Stage Alzheimer's Disease Discovered in Urine | Inside Precision Medicine

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

Detailed data for the companies’ medicine lecanemab help to validate an announcement from two months ago that a key clinical trial had succeeded.

What to make of Eisai and Biogen’s latest Alzheimer’s drug data | BioPharma Dive

Elon Musk says Neuralink’s brain-machine interface could enter human studies next year

Musk: Neuralink brain-machine interface nears human studies (statnews.com)

FDA approves Rebyota, Ferring's poop-based drug to fight C. diff infection

FDA approves Rebyota, Ferring’s poop-based drug to fight C. diff infection – Endpoints News (endpts.com)

The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells

The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells: Cell Stem Cell

Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease

Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease: Cell Stem Cell